Franchise Login | Webmail Login | LIS Login | Panel Report | Patient Report
+91 11 30611432 , 30611467
+91 11 30611432 , 30611467 
- Imu Life
- Cancer HOT SPOT Panel – 50 Genes by NGS
- Cell-free or Circulating Tumour DNA (ctDNA)
- Circulating Tumor Cells
- Foundation one (solid tumors)
- PD – L1 TESTING
- BRCA 1 & 2
- Lung Cancer -ROS 1 Gene & Met Gene
- Panorama Test
- Syndrome Evaluation System
- MammaPrint Test
- Myeloproliferative Leukemia (MPL) Mutation Analysis
- Calreticulin Mutation
Myeloproliferative Leukemia (MPL) Mutation Analysis
View / Download
- MPL found at 1p34, encodes the thrombopoetin receptor required for platelet production.
- Upto 5% of JAK2V617F negative ET or Primary myelofibrosis (PMF) patients are reported to exhibit a MPL exon 10 mutation
- Acquired MPL mutations (W515L & W515K) have been reported in Essential thrombocythemia (ET) (1%) & Myelofibrosis(MF) (5-7%) cases but not in Polycythemia vera (PV) & are associated with severe anemia.
- An inherited MPL mutation (S505N; exon 10) has also been detected in patients with hereditary thrombocythemia.
Clinical Utility
- Identification of MPL mutations can aid in the diagnosis of a myeloproliferative neoplasm and is highly suggestive of either PMF or ET.
- MPL mutation would be beneficial in the differential diagnosis of unexplained Thrombocytosis or myelofibrosis.
When to go for the test:
Testing is recommended in patients with a clinical picture suggestive of clear picture of ET or PMF or who were found to be negative for the JAK2V617F mutation.
